Approval · Notice of Compliance 30479 · 2023
MYLAN-HYDROXYUREA: Notice of Compliance 30479
Issued April 5, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30479
- Date
- April 5, 2023
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to The Product Monograph
- Canadian reference product
- HYDREA
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MYLAN-HYDROXYUREA | Not yet assigned | — |
Medicinal ingredients
- HYDROXYUREA 500 MG per CAP